mRNA |
GSK525762A |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.6 |
mRNA |
KPT185 |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.6 |
mRNA |
BRD8958 |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.6 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
JW-7-24-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
BRD-K17060750 |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.6 |
mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.6 |
mRNA |
fingolimod |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
BRD-K14844214 |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.6 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.6 |